A synthetic agonist of the cannabinoid receptor 1 (CB1R). ACPA is considered to be a selective cannabinoid agonist as it binds primarily to the CB1R and has low affinity to the cannabinoid receptor 2
相关文献及参考
Hillard, C.J. et al.: J. Pharmacol. Exp. Therap., 289, 1427 (1999); Franklin, A. et al.: Eur. J. Pharmacol., 474, 195 (2003);